TABLE 2.
CMV viral load by assaya
| Challenge | Assay | n | log10 copies/ml |
n | log10 IU/mlb |
||||
|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Median (IQR) | Range | Mean (SD) | Median (IQR) | Range | ||||
| VLS/VLS2-03 | Roche COBAS | 18 | 3.09 (0.14) | 3.11 (0.18) | 0.54 | 13 | 2.91 (0.22) | 2.97 (0.10) | 0.77 |
| Qiagen | 39 | 3.02 (0.35) | 3.07 (0.35) | 1.61 | 11 | 3.17 (0.23) | 3.21 (0.21) | 0.87 | |
| Others | 117 | 3.19 (0.42) | 3.20 (0.47) | 2.36 | 31 | 3.29 (0.54) | 3.40 (0.81) | 2.22 | |
| VLS/VLS2-04 | Roche COBAS | 18 | 4.86 (0.34) | 4.80 (0.10) | 1.51 | 13 | 4.72 (0.10) | 4.74 (0.09) | 0.35 |
| Qiagen | 40 | 4.89 (0.34) | 4.99 (0.33) | 1.85 | 11 | 4.99 (0.16) | 4.97 (0.25) | 0.53 | |
| Others | 124 | 4.91 (0.53) | 4.92 (0.62) | 3.35 | 32 | 5.02 (0.58) | 5.11 (0.63) | 2.90 | |
| VLS/VLS2-13 | Roche COBAS | 15 | 4.64 (0.12) | 4.66 (0.12) | 0.50 | 27 | 4.59 (0.12) | 4.60 (0.15) | 0.60 |
| Qiagen | 38 | 5.16 (0.26) | 5.19 (0.37) | 1.38 | 14 | 5.18 (0.26) | 5.19 (0.20) | 0.92 | |
| Others | 113 | 5.11 (0.51) | 5.23 (0.62) | 3.14 | 34 | 5.37 (0.49) | 5.36 (0.79) | 2.14 | |
| VLS/VLS2-14 | Roche COBAS | 8 | 2.18 (0.05) | 2.18 (0.01) | 0.18 | 20 | 2.18 (0.06) | 2.14 (0.08) | 0.21 |
| Qiagen | 35 | 2.62 (0.26) | 2.65 (0.30) | 1.34 | 14 | 2.61 (0.33) | 2.66 (0.26) | 1.33 | |
| Others | 91 | 2.84 (0.50) | 2.87 (0.58) | 3.28 | 32 | 2.89 (0.56) | 2.86 (0.88) | 2.76 | |
a
n, number of labs; SD, standard deviation; IQR, interquartile range.
b
In the version of this article published on 25 January 2017, this heading incorrectly read “log10 copies/ml.” This was changed in the version published on 22 November 2017.